局部晚期甲状腺癌新辅助治疗进展和思考OACSTPCD
Advances and Reflections on Neoadjuvant Therapy for Locally Advanced Thyroid Cancer
绝大多数甲状腺癌预后良好,但局部晚期甲状腺癌的治疗却是一个棘手的问题.随着靶向和免疫治疗的广泛应用,将其用于局部晚期甲状腺癌的新辅助治疗成为新的治疗方向.本文对不同病理类型甲状腺癌相关的新辅助化疗、放疗、靶向及免疫治疗研究进行总结,重点阐述了新辅助治疗中应用靶向及免疫治疗药物的最新进展和思考,为局部晚期甲状腺癌的临床治疗提供更多选择.
The vast majority of thyroid cancers show a good prognosis.However,the treatment of locally advanced thyroid cancer presents a huge problem.The wide application of targeted and immunotherapy in neoadjuvant therapy for locally advanced thyroid cancer has become a new therapeutic direction.This article summarizes the research on neoadjuvant chemotherapy,radiotherapy,and targeted therapy and immunotherapy related to various pathological types of thyroid cancer,with a focus on the recent advancements and thoughts on the application of targeted and immunotherapeutic drugs in neoadjuvant therapy.The results provide additional options for the clinical treatment of locally advanced thyroid cancer.
樊倩妤;黄秋艺;陈健
430079 武汉,华中科技大学同济医学院附属湖北肿瘤医院头颈外科
临床医学
甲状腺癌新辅助治疗分子靶向治疗免疫治疗
Thyroid cancerNeoadjuvant therapyMolecular targeted therapyImmunotherapy
《肿瘤防治研究》 2024 (004)
290-295 / 6
Research Projects of Biomedical Center of Hubei Cancer Hospital 湖北省肿瘤医院生物医学中心专项科研基金(2022SWZX11)
评论